Rhön-Klinikum Aktiengesellschaft (ETR:RHK) has received an average rating of “Hold” from the ten research firms that are covering the company, Marketbeat reports. Four research analysts have rated the stock with a sell rating and six have issued a hold rating on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is €25.05 ($29.82).

Several equities analysts have issued reports on the stock. Berenberg Bank set a €26.50 ($31.55) price target on shares of Rhön-Klinikum Aktiengesellschaft and gave the company a “neutral” rating in a research report on Wednesday, September 20th. Deutsche Bank set a €22.00 ($26.19) price target on shares of Rhön-Klinikum Aktiengesellschaft and gave the company a “neutral” rating in a research report on Monday, November 13th. Commerzbank set a €25.00 ($29.76) price target on shares of Rhön-Klinikum Aktiengesellschaft and gave the company a “neutral” rating in a research report on Monday, September 18th. DZ Bank restated a “sell” rating on shares of Rhön-Klinikum Aktiengesellschaft in a research report on Tuesday, August 29th. Finally, Independent Research set a €28.00 ($33.33) price target on shares of Rhön-Klinikum Aktiengesellschaft and gave the company a “neutral” rating in a research report on Monday, August 14th.

Rhön-Klinikum Aktiengesellschaft (ETR:RHK) opened at €29.68 ($35.33) on Wednesday. Rhön-Klinikum Aktiengesellschaft has a 12-month low of €22.66 ($26.98) and a 12-month high of €30.65 ($36.49).

ILLEGAL ACTIVITY NOTICE: “Rhön-Klinikum Aktiengesellschaft (RHK) Given Consensus Rating of “Hold” by Brokerages” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2017/12/06/rhon-klinikum-aktiengesellschaft-rhk-given-consensus-rating-of-hold-by-brokerages.html.

About Rhön-Klinikum Aktiengesellschaft

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.

Analyst Recommendations for Rhön-Klinikum Aktiengesellschaft (ETR:RHK)

Receive News & Ratings for Rhön-Klinikum Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhön-Klinikum Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.